Stockscreener 앱 받기
0.4107
7.71%
-0.0393
Reshape Lifesciences Inc 주식(RSLS)의 최신 뉴스
ReShape Lifesciences shareholders approve key proposals By Investing.com - Investing.com Australia
Nasdaq Tumbles 100 Points; UniFirst Posts Upbeat Earnings - Benzinga
ReShape Lifesciences shareholders approve key proposals - Investing.com
Stock Market News For Apr 2, 2025 - Yahoo Finance
ReShape Lifesciences Delays Yearly Report Filing - TipRanks
Global Bariatric Surgeries Market to Hit USD 27.64 Billion - GlobeNewswire
Dow Dips Over 400 Points; ISM Manufacturing PMI Falls In March - Benzinga
Sands Capital Select Growth Fund Sold Edwards Lifesciences Corporation (EW) For Better Opportunities - Yahoo Finance
Nueva Network Launches Que-Onnda Radio in Washington DC & Boston - Yahoo Finance
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Frazier Life Sciences Welcomes Chris Aakre as Principal of Company Creation - Yahoo Finance
Why XPeng Inc. (XPEV) Went Up On Monday? - Yahoo Finance
Why Mr. Cooper Group Inc. (COOP) Went Up On Monday? - Yahoo Finance
WELL HEALTH TECHNOLOGIES CORP. EARLY WARNING NEWS RELEASE - Yahoo Finance
Analysts at Cantor, formerly headed by Lutnick, call for Kennedy's dismissal - Yahoo Finance
Lytus Technologies Adjusts Market Strategy and Transition to OTC Markets - Yahoo Finance
Novvia Group Acquires MegaChem - Yahoo Finance
ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week - MSN
Bio-Techne Opens New Customer Experience Centre in Germany - Yahoo Finance
The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics - Yahoo Finance
Investors Heavily Search Occidental Petroleum Corporation (OXY): Here is What You Need to Know - Yahoo Finance
Pearson Expands Professional Learning Capabilities with New Skilling Partner Program - Yahoo Finance
The legal problems facing a new Trump TikTok rescue — and why they may not matter - Yahoo Finance
Is Palantir Technologies Inc. (NASDAQ:PLTR) The Best Stock to Buy and Hold for 2 Years? - Yahoo Finance
Wave Life Sciences unveils Phase II data for DMD therapy, WVE-N531 - Yahoo Finance
Duchesnay Pharmaceutical Group recognized for commitment to well-being of its employees as winner of 2025 Healthiest Workplace Award - Yahoo Finance
Wave Life Sciences (WVE) Stock Jumps 6.1%: Will It Continue to Soar? - Yahoo Finance
RSLS stock touches 52-week low at $0.49 amid sharp annual decline - Investing.com Australia
RSLS stock touches 52-week low at $0.49 amid sharp annual decline By Investing.com - Investing.com South Africa
US jet fuel imports surge as Nigeria's Dangote refinery pushes barrels west - Yahoo Finance
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AVTE, RSLS on Behalf of Shareholders - GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AVTE, RSLS on Behalf of Shareholders - GlobeNewswire Inc.
Maravai Lifesciences price target lowered to $5 from $10 at Stifel - Yahoo Finance
RESHAPE LIFESCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ReShape Lifesciences Inc.RSLS - Business Wire
ReShape Lifesciences Faces Board Resignation Challenge - TipRanks
RSLS stock touches 52-week low at $0.61 amid market challenges By Investing.com - Investing.com South Africa
RSLS stock touches 52-week low at $0.61 amid market challenges - Investing.com India
Pre-market Movers: REVB, QSI, EYEN, NAOV ... - RTTNews
REDFIN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Redfin CorporationRDFN - Business Wire
ENDO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Endo, Inc.NDOI - Business Wire
Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial - Yahoo Finance
First national perception survey of Food is Medicine programs shows strong public support - EurekAlert!
Ratio Analysis: Unpacking ReShape Lifesciences Inc (RSLS)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Grow - Asianet Newsable
ReShape Lifesciences® Receives Notice of Allowance for Vagus Nerve Modulation Patent Aimed at Improving Glycemic Control - Nasdaq
ReShape Lifesciences® Receives Notice of Allowance for U.S. - GlobeNewswire
ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology - Yahoo
ReShape Lifesciences Patents Breakthrough Diabetes Neuromodulation System - Stock Titan
ReShape Lifesciences, Inc. to Host Earnings Call - ACCESS Newswire
RSLS stock touches 52-week low at $0.87 amid market challenges - Investing.com Canada
RSLS stock touches 52-week low at $0.87 amid market challenges By Investing.com - Investing.com South Africa
Global Synthetic Biosensors Market Size to Hit USD 49.87 Billion by 2032 -Coherent Market Insights - openPR
4 AI Stocks Poised for Explosive Growth in 2025Are You In? - Yahoo Finance
WAVE Life Sciences Ltd (WVE) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Clinical ... - Yahoo Finance
Gorilla Technology Secures Landmark $1.8 Billion Agreement to Drive Thailand's Largest Smart Grid and AI-Powered Energy Transformation - Yahoo Finance
Why Tiziana Life Sciences Ltd (TLSA) is Skyrocketing So Far in 2025 - Yahoo Finance
Minimally Invasive Bariatric Surgery Equipment Market Accelerating Digital Transformation for a Smarter Future - ExpressVartha
RSLS Stock Touches 52-Week Low at $0.99 Amid Market Challenges - Investing.com Canada
RSLS Stock Touches 52-Week Low at $0.99 Amid Market Challenges By Investing.com - Investing.com South Africa
0.62%
0.92%
자본화:
|
볼륨(24시간):